Loading ...
Sorry, an error occurred while loading the content.

RE: Global Fund - Round 6 Grants

Expand Messages
  • Ashok Rau
    1. NEWS: Global Fund Approves Sixth Round of Grants The Global Fund board has approved 85 Round 6 grants that will cost $846 million over the first two years
    Message 1 of 2 , Nov 4, 2006
    • 0 Attachment
      1. NEWS: Global Fund Approves Sixth Round of Grants

      The Global Fund board has approved 85 Round 6 grants that will cost $846 million over the first two years and $2,519 m. over five years. As a result of recent new pledges, the Fund has sufficient money to pay for all of these grants.

      2. NEWS: Round Six Decisions

      A detailed listing and analysis is provided of which Round 6 proposals have been approved.
      1. NEWS: Global Fund Approves Sixth Round of Grants
      + + + + + + + + + + + + + + + + + + +

      At its fourteenth board meeting held in Guatemala from Tuesday morning through yesterday afternoon, Friday, the Global Fund board approved 85 Round 6 grants that will cost $846 million over the first two years and $2,519 m. over five years. (For a complete list of approved and non-approved proposals, see below.) As a result of recent new pledges, the Fund has sufficient money to pay for all grants that were recommended by the Technical Review Panel.

      In Round 6, the two-year cost of all eligible submitted proposals was down 24% from the Round 5 level; but the cost of those actually approved was up 17% from the Round 5 level. This was mainly because the percentage of proposals approved went up from 31% in Round 5 to 43% in Round 6. The average cost of the first two years of each Round 6 approved proposal was $10 million, down from $11.5 million in Round 5.

      In Round 6, an unusually high 62% of TB proposals were approved, up from 46% in Round 5. The percentages of HIV/AIDS and malaria proposals approved were 39% and 32%, respectively.

      The success rates by region ranged from 24% (4 proposals approved out of 17 submitted) in Latin America and the Caribbean, to 77% (10 out of 13) in the Western Pacific. The Western Pacific has had the highest success rates in all of the last three Rounds.

      The Board's decisions as to which proposals to approve was, as always, entirely based on the advice it received from the Technical Review Panel (TRP), an independent body of 26 experts from around the world. No board members or Secretariat employees are members of the TRP.

      The following tables summarize Round 6 results.

      Table 1: Results by Round

      Number of eligible proposals Percent Budget for Years 1-2 Percent
      Round 1: Submitted 204 100% c. $1,500 m. 100%
      Of which, Approved 58 28% $578 m. c. 39%

      Round 2: Submitted 229 100% $2,137 m. 100%
      Of which, Approved 98 43% $878 m. 41%

      Round 3: Submitted 180 100% $1,853 m. 100%
      Of which, Approved 71 39% $623 m. 34%

      Round 4: Submitted 173 100% $2,512 m. 100%
      Of which, Approved 69 40% $968 m. 39%

      Round 5: Submitted 202 100% $3,298 m. 100%
      Of which, Approved 63 31% $726 m. 22%

      Round 6: Submitted 196 100% $2,519 m. 100%
      Of which, Approved 85 43% $846 m. 34%


      Table 2: Disease Component Results by Round

      No. of eligible proposals submitted,
      number approved, and
      % of submitted proposals approved Budget for Years 1-2 of approved proposals
      Round 4 Round 5 Round 6 Round 4 Round 5 Round 6
      HIV/AIDS 72 27 38% 67 25 37% 82 32 39% $468 m. (48%) $288 m. (40%) $453 m. (54%)
      Malaria 46 23 50% 57 13 23% 59 19 32% $406 m. (42%) $198 m. (27%) $203 m. (24%)
      TB 48 19 40% 48 22 46% 55 34 62% $94 m. (10%) $197 m. (27%) $190 m. (22%)
      Other 7 0 0% 30 3 10% n/a $0 m. (0%) $43 m. (6%) n/a
      TOTAL 173 69 40% 202 63 31% 196 85 43% $968 m. (100%) $726 m. (100%) $846 m. (100%)


      Table 3: Region Results by Round

      No. of eligible proposals submitted,
      number approved, and
      % of submitted proposals approved Budget for Years 1-2 of approved proposals
      Round 4 Round 5 Round 6 Round 4 Round 5 Round 6
      Africa 86 34 40% 105 32 30% 93 32 34% $663 m. (68%) $484 m. (67%) $381 m. (45%)
      Southeast Asia 18 8 44% 19 3 16% 21 11 52% $111 m. (11%) $33 m. (5%) $165 m. (19%)
      Western Pacific 17 9 53% 17 10 59% 13 10 77% $84 m. (9%) $91 m. (13%) $72 m. (9%)
      Eastern Med. 17 5 29% 27 4 15% 25 11 44% $31 m. (3%) $28 m. (4%) $62 m. (7%)
      Europe 21 7 33% 21 9 43% 27 17 63% $53 m. (5%) $26 m. (4%) $119 m. (14%)
      Americas 14 6 43% 13 5 38% 17 4 24% $26 m. (3%) $64 m. (9%) $48 m. (6%)
      TOTAL 173 69 40% 202 63 31% 196 85 43% $968 m. (100%) $726 m. (100%) $846 m. (100%)


      Table 4: Outcome of Secretariat Screening Panel Review of Eligibility, by Round

      Round 5 Round 6
      Type of Applicant Number of Applicants Eligible Applicants Number of Applicants Eligible Applicants
      CCM 90 89 96 93
      Sub-CCM 1 1 1 1
      Regional Organization 9 2 10 9
      Regional Coordinating Mechanism 3 3 1 1
      Non-CCM 64 3 36 4
      Total 167 98 (59%) 144 108 (75%)

      Other highlights of Round 6 include the following:

      • The TRP commented, “In some cases, for reasons the TRP cannot comprehend, some applicants appear to repeatedly ignore the TRP’s advice and comments on prior proposals. These are in stark contrast to the many applicants in Round 6 who provided specific and adequate responses to all or most of the weaknesses identified in their prior proposals. Where this was the case, these proposals usually tended to be recommended for funding in Round 6. The TRP believes that directly and comprehensively addressing the problems identified in a prior unsuccessful proposal is perhaps the most effective approach to ensuring a successful new application.”

      • In Round 6, three approved proposals had five-year budgets in excess of $100 million. These were from India (HIV/AIDS, $259 m.), Ukraine (HIV/AIDS, $151 m.) and South Africa (HIV/AIDS, $103 m.). And eight non-approved proposals had five-year budgets in excess of $100 million. These were from Democratic Republic of Congo, Ethiopia, Haiti, Madagascar, Tanzania (2 proposals) and Uganda (2 proposals).

      • As always, and as required by the Board, the TRP did not take into account availability of funds when it decided which proposals to recommend for approval.

      • The budget breakdown of the approved Round 6 proposals was: drugs 15% (down from 21% in Round 5); commodities 22%; planning and administration 18%; human resources 13%; infrastructure 11%; training 12%; and other 9%.

      • The Round 6 success rate is equal to the highest ever success rate of 43%, which was recorded in Round 2.

      • The TRP commented, “The trend, noted in Round 5, away from very large and ambitious scale up programs of antiretroviral therapy was again a feature of Round 6. In this Round, the vast majority of HIV/AIDS proposals were of a more modest nature, perhaps reflecting the understanding by applicant countries of the difficulties of implementing very large scale programs over a relatively short period of time.”

      • Further details are available below.
      Based on advise from the Technical Review Panel (TRP), the Board divides eligible proposals into five Categories, as follows:

      • Category 1: Approved proposals requiring no or minor clarifications, which need to be provided within 4 weeks and then given a final approval by the TRP Chair and/or Vice-Chair.

      • Category 2: Proposals that are provisionally approved subject to the required clarifications being provided within a limited timeframe (6 weeks for the applicant to respond to the TRP queries, 4 months to obtain the final TRP approval should further clarifications be requested). The primary reviewer and secondary reviewer as well as TRP Chair and /or Vice-Chair need to give final approval.

      • Category 2B: Similar to Category 2A, but regarded as relatively weak, on grounds of technical merit and/or issues of feasibility and likelihood of effective implementation.

      • Category 3: Not approved in their present form, but applicants are encouraged to submit an improved proposal in some future Round.

      • Category 4: Rejected.

      The number of Round 6 grants per Category was as follows:

      Table 5: Round 6 results by Category

      Explanation Number of proposals Budget
      Years 1-2 Budget
      Years 1-5
      Approved: Category 1 9 $69 m. $150 m.
      Approved: Category 2 48 $437 m. $977 m.
      Approved: Category 2B 28 $341 m. $929 m.
      Subtotal: All Approved Proposals: 85 $846 m. $2,056 m.
      Not Approved: Category 3 97 $1,519 m. $3,747 m.
      Not Approved: Category 4 14 $154 m. $305 m.
      Subtotal: All Non-Approved Proposals: 111 $1,673 m. $4,052 m.
      Total: All Proposals 196 $2,519 m. $6,108 m.


      Round 6 results by country were as follows:

      Table 6: Round 6 results by country

      Country / Countries Applicant Decision Component Budget
      Years 1-2 Budget
      Years 1-5
      Afghanistan CCM Not approved: Category 3 HIV/AIDS $15,481,701 $35,820,001
      Afghanistan CCM Not approved: Category 3 TB $15,458,931 $37,964,223
      Armenia CCM Not approved: Category 4 Malaria $1,716,380 $2,804,333
      Azerbaijan CCM Not approved: Category 3 Malaria $2,438,744 $4,834,597
      Bangladesh CCM Approved: Category 1 Malaria $18,587,179 $39,062,586
      Bangladesh CCM Approved: Category 2B HIV/AIDS $13,998,844 $40,002,452
      Belarus CCM Approved: Category 2B TB $6,083,814 $14,774,359
      Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama Regional Org. (Central American network for persons living with HIV/AIDS) Not approved: Category 4 HIV/AIDS $6,118,200 $13,518,001
      Benin CCM Approved: Category 2 TB $4,812,685 $9,401,518
      Benin CCM Not approved: Category 3 Malaria $14,164,549 $40,140,099
      Benin, Burkina Faso, Central African Republic, Côte d’Ivoire, Liberia, Mali Regional Org. (UN Foundation, for the Measles-Malaria Partnership) Not approved: Category 4 Malaria $45,797,837 $45,797,837
      Bhutan CCM Approved: Category 2 TB $884,690 $1,773,135
      Bhutan CCM Approved: Category 2B HIV/AIDS $1,812,825 $3,596,325
      Bhutan CCM Not approved: Category 3 Malaria $1,834,725 $3,819,875
      Bosnia and Herzegovina CCM Approved: Category 2B TB $3,302,606 $6,880,708
      Botswana CCM Not approved: Category 3 TB $2,066,795 $2,898,720
      Botswana, Lesotho, Malawi, Mozambique, Namibia, South Africa, Swaziland, Tanzania, Zambia, Zimbabwe Regional Org. (Soul City: Institute for Health and Development Communication) Not approved: Category 4 HIV/AIDS $27,511,611 $76,135,198
      Bulgaria CCM Approved: Category 2B TB $8,968,233 $19,703,709
      Burkina Faso CCM Approved: Category 2 HIV/AIDS $27,691,230 $60,000,048
      Burkina Faso CCM Not approved: Category 3 Malaria $12,169,089 $27,852,482
      Burundi CCM Not approved: Category 3 Malaria $13,881,173 $25,421,843
      Burundi, DRC, Kenya, Rwanda, Uganda, Tanzania Regional Org. (Great Lakes Initiative On HIV/AIDS) Not approved: Category 4 HIV/AIDS $16,380,500 $35,398,100
      Burundi, Rwanda Regional Org. (East African Network for Monitoring Antimalarial Treatment) Not approved: Category 4 Malaria $3,006,181 $3,923,349
      Cambodia CCM Approved: Category 2 Malaria $13,148,613 $31,191,393
      Cambodia CCM Not approved: Category 3 HIV/AIDS $13,796,409 $54,225,879
      Cambodia CCM Not approved: Category 3 TB $2,192,363 $6,125,536
      Cameroon CCM Not approved: Category 3 HIV/AIDS $8,842,899 $15,579,150
      Cameroon CCM Not approved: Category 3 Malaria $9,522,466 $27,387,624
      Cameroon CCM Not approved: Category 3 TB $11,554,563 $18,557,034
      Central African Republic CCM Not approved: Category 3 HIV/AIDS $9,940,350 $33,723,417
      Central African Republic CCM Not approved: Category 3 Malaria $5,875,492 $8,011,650
      Central African Republic, Congo, Equatorial Guinea, Gabon Regional Org. (Secretary General of Economic Community of Central African States) Not approved: Category 3 HIV/AIDS $6,657,961 $16,391,154
      Chad CCM Not approved: Category 3 Malaria $9,696,237 $32,008,824
      China CCM Approved: Category 2 HIV/AIDS $5,812,875 $14,395,715
      China CCM Approved: Category 2B Malaria $7,047,932 $16,808,186
      Colombia CCM Not approved: Category 3 HIV/AIDS $12,506,437 $28,517,825
      Comoros CCM Not approved: Category 3 HIV/AIDS $3,423,946 $7,213,882
      Comoros CCM Not approved: Category 3 Malaria $4,022,831 $7,993,136
      Congo CCM Not approved: Category 3 Malaria $28,013,479 $48,624,009
      Congo (DR of) CCM Approved: Category 2 TB $8,532,576 $12,098,109
      Congo (DR of) CCM Not approved: Category 3 HIV/AIDS $42,120,821 $130,540,223
      Congo (DR of) CCM Not approved: Category 3 Malaria $25,868,570 $37,846,540
      Côte d’Ivoire CCM Approved: Category 2 Malaria $9,121,504 $17,271,965
      Côte d’Ivoire CCM Approved: Category 2B TB $3,489,404 $7,068,427
      Côte d’Ivoire CCM Not approved: Category 3 HIV/AIDS $12,130,403 $50,061,748
      Côte d’Ivoire, Ghana, Togo, Benin, Nigeria Regional Org. (Abidjan-Lagos Corridor Organization) Approved: Category 2 HIV/AIDS $19,122,500 $45,610,500
      Côte d’Ivoire, Guinea, Liberia, Sierra Leone Regional Org. (Mano River Union Secretariat) Not approved: Category 3 HIV/AIDS $15,472,689 $27,527,333
      Cuba CCM Approved: Category 2 HIV/AIDS $14,369,743 $36,123,056
      Cuba CCM Not approved: Category 3 TB $3,497,417 $9,686,494
      Dijbouti CCM Approved: Category 2 HIV/AIDS $2,719,910 $11,298,977
      Dijbouti CCM Approved: Category 2 Malaria $2,611,945 $3,933,976
      Dijbouti CCM Approved: Category 2 TB $1,143,735 $3,558,810
      Dominican Republic CCM Not approved: Category 3 Malaria $2,994,675 $6,267,052
      Ecuador, Guatemala, Mexico, Nicaragua, Peru, Uraguay Regional Coordinating Mechanism Not approved: Category 4 HIV/AIDS $12,189,750 $28,955,156
      Egypt CCM Approved: Category 2B TB $5,375,548 $9,965,390
      Egypt CCM Not approved: Category 3 HIV/AIDS $5,412,750 $11,619,700
      El Salvador CCM Not approved: Category 3 HIV/AIDS $15,342,600 $37,821,680
      El Salvador CCM Not approved: Category 3 TB $3,283,596 $8,497,574
      Eritrea CCM Approved: Category 2 Malaria $5,943,130 $13,374,247
      Eritrea CCM Approved: Category 2 TB $5,578,834 $13,302,028
      Ethiopia CCM Approved: Category 2B TB $12,104,974 $44,434,133
      Ethiopia CCM Not approved: Category 3 HIV/AIDS $56,494,994 $193,864,789
      Ethiopia CCM Not approved: Category 3 Malaria $17,162,130 $49,947,701
      Gabon CCM Not approved: Category 4 Malaria $8,338,037 $20,546,237
      Georgia CCM Approved: Category 1 TB $9,345,636 $10,955,450
      Georgia CCM Approved: Category 2 HIV/AIDS $6,194,362 $11,449,497
      Georgia CCM Approved: Category 2 Malaria $1,664,960 $3,334,190
      Guatemala CCM Approved: Category 2 TB $3,733,873 $8,136,149
      Guinea CCM Approved: Category 2 HIV/AIDS $4,859,358 $20,419,474
      Guinea CCM Approved: Category 2B Malaria $17,349,399 $26,978,927
      Guinea-Bissau CCM Approved: Category 2B Malaria $3,438,484 $12,816,656
      Guinea-Bissau CCM Not approved: Category 3 HIV/AIDS $6,715,035 $20,933,476
      Guinea-Bissau CCM Not approved: Category 3 TB $1,503,686 $3,381,515
      Haiti CCM Not approved: Category 3 HIV/AIDS $48,422,668 $137,232,190
      Honduras CCM Not approved: Category 3 HIV/AIDS $17,810,301 $38,376,897
      Honduras CCM Not approved: Category 3 Malaria $6,493,366 $12,825,085
      Honduras CCM Not approved: Category 3 TB $6,315,790 $11,052,632
      India CCM Approved: Category 2 TB $9,072,464 $24,271,555
      India CCM Approved: Category 2B HIV/AIDS $75,954,670 $259,211,574
      India CCM Not approved: Category 3 Malaria $14,763,903 $39,267,508
      Indonesia CCM Approved: Category 2 Malaria $27,727,920 $57,965,100
      Indonesia CCM Not approved: Category 3 HIV/AIDS $5,190,619 $14,735,703
      Iraq CCM Approved: Category 1 TB $6,443,900 $14,553,900
      Iraq CCM Not approved: Category 3 HIV/AIDS $4,272,326 $4,272,326
      Iraq CCM Not approved: Category 3 Malaria $3,179,244 $6,543,244
      Jordan CCM Approved: Category 2 HIV/AIDS $3,069,508 $6,800,716
      Kazakhstan CCM Approved: Category 1 TB $5,442,598 $9,842,621
      Kenya CCM Not approved: Category 3 HIV/AIDS $13,686,258 $26,767,049
      Kenya CCM Not approved: Category 4 Malaria $4,082,093 $8,873,241
      Kenya, Uganda Regional Org. (Global Health Action, Inc.) Not approved: Category 4 HIV/AIDS $7,426,148 $19,693,769
      Kenyan CCM Approved: Category 2 TB $4,217,269 $9,171,790
      Kosovo CCM Not approved: Category 3 HIV/AIDS $2,772,782 $5,926,482
      Kosovo Non-CCM (ALB-MED) Not approved: Category 4 HIV/AIDS $738,109 $738,109
      Kyrgyzstan CCM Approved: Category 2 TB $4,244,578 $9,995,446
      Lao PDR CCM Approved: Category 2 HIV/AIDS $3,418,698 $8,978,927
      Lao PDR CCM Approved: Category 2 Malaria $1,726,701 $4,099,092
      Lesotho CCM Approved: Category 2B TB $3,829,664 $6,581,970
      Lesotho CCM Not approved: Category 3 HIV/AIDS $15,145,130 $52,727,643
      Liberia CCM Approved: Category 2B HIV/AIDS $13,857,723 $44,281,569
      Liberia CCM Not approved: Category 3 Malaria $15,558,819 $29,368,547
      Liberia CCM Not approved: Category 3 TB $5,746,059 $13,409,498
      Macedonia CCM Not approved: Category 3 HIV/AIDS $5,987,500 $14,957,266
      Madagascar CCM Not approved: Category 3 HIV/AIDS $23,925,565 $51,570,146
      Madagascar CCM Not approved: Category 3 Malaria $72,297,995 $225,433,100
      Madagascar CCM Not approved: Category 3 TB $4,082,076 $8,736,174
      Malawi CCM Not approved: Category 3 HIV/AIDS $35,229,821 $90,403,880
      Malawi CCM Not approved: Category 3 Malaria $17,996,090 $64,952,812
      Maldives CCM Approved: Category 2B HIV/AIDS $2,655,685 $4,865,956
      Mali CCM Approved: Category 2B Malaria $9,222,572 $26,659,632
      Mauritania CCM Approved: Category 2 Malaria $4,495,126 $14,502,141
      Mauritania CCM Approved: Category 2 TB $4,441,686 $9,352,445
      Moldova CCM Approved: Category 1 HIV/AIDS $6,411,072 $15,940,711
      Moldova CCM Approved: Category 2 TB $5,786,890 $11,976,633
      Mongolia CCM Not approved: Category 3 HIV/AIDS $5,214,505 $12,138,067
      Montenegro CCM Approved: Category 1 TB $1,073,811 $1,651,006
      Morocco CCM Approved: Category 2 HIV/AIDS $10,680,798 $26,453,910
      Morocco CCM Approved: Category 2 TB $2,221,975 $4,157,800
      Mozambique CCM Approved: Category 2 HIV/AIDS $22,748,853 $76,044,549
      Mozambique CCM Approved: Category 2B Malaria $25,591,825 $36,747,308
      Mozambique CCM Not approved: Category 3 TB $16,721,868 $25,026,133
      Namibia CCM Approved: Category 2 Malaria $9,919,565 $15,820,160
      Namibia CCM Not approved: Category 3 HIV/AIDS $13,312,950 $50,303,667
      Nepal CCM Not approved: Category 3 HIV/AIDS $8,739,192 $29,034,173
      Nepal CCM Not approved: Category 3 Malaria $5,187,646 $17,863,993
      Nepal CCM Not approved: Category 3 TB $4,589,953 $15,961,562
      Nepal Non-CCM (Family Health International) Not approved: Category 4 HIV/AIDS $7,381,007 $21,105,841
      Niger CCM Not approved: Category 3 HIV/AIDS $7,537,006 $21,959,530
      Niger CCM Not approved: Category 3 TB $5,648,199 $8,184,993
      Niger CCM Not approved: Category 4 Malaria $12,254,867 $25,632,832
      Nigeria CCM Not approved: Category 3 HIV/AIDS $3,836,085 $22,599,482
      Nigeria CCM Not approved: Category 3 Malaria $29,152,570 $30,709,320
      Pakistan CCM Not approved: Category 3 HIV/AIDS $21,827,272 $73,733,095
      Pakistan CCM Not approved: Category 3 Malaria $7,270,655 $15,901,134
      Pakistan CCM Not approved: Category 3 TB $22,568,553 $56,020,759
      Papua New Guinea CCM Approved: Category 1 TB $5,007,912 $20,869,303
      Paraguay CCM Approved: Category 1 HIV/AIDS $3,471,892 $9,110,757
      Peru CCM Approved: Category 2B HIV/AIDS $26,396,819 $41,348,625
      Peru CCM Not approved: Category 3 TB $27,679,354 $55,822,507
      Philippines CCM Approved: Category 2B HIV/AIDS $7,474,964 $18,434,190
      Philippines CCM Approved: Category 2B Malaria $16,297,659 $22,344,786
      Romania CCM Approved: Category 2 HIV/AIDS $8,229,885 $11,567,365
      Romania CCM Approved: Category 2 TB $4,606,269 $10,200,345
      Rwanda CCM Approved: Category 2 HIV/AIDS $31,563,456 $58,917,110
      Rwanda CCM Approved: Category 2 TB $2,779,743 $7,525,352
      Rwanda CCM Not approved: Category 3 Malaria $7,296,260 $10,716,123
      Sénégal CCM Approved: Category 2 HIV/AIDS $10,368,195 $28,893,265
      Sénégal CCM Not approved: Category 3 TB $7,839,600 $14,925,041
      Serbia CCM Approved: Category 2 HIV/AIDS $5,922,119 $12,159,491
      Sierra Leone CCM Approved: Category 2 HIV/AIDS $9,627,939 $26,482,276
      Sierra Leone CCM Not approved: Category 3 Malaria $20,536,213 $28,436,907
      Sierra Leone CCM Not approved: Category 3 TB $6,602,108 $15,264,339
      Somalia Non-CCM (Somalia Aid Coordination Body Health Sector Committee) Approved: Category 1 Malaria $13,096,942 $27,679,264
      Somalia Non-CCM (AMIRDF) Not approved: Category 4 HIV/AIDS $575,000 $1,400,000
      South Africa CCM Approved: Category 2 HIV/AIDS $55,771,311 $102,813,863
      Sri Lanka CCM Approved: Category 2 HIV/AIDS $1,009,760 $1,884,360
      Sri Lanka CCM Approved: Category 2B TB $5,190,641 $14,291,187
      Sri Lanka CCM Not approved: Category 3 Malaria $5,477,185 $12,294,174
      Sudan, North CCM Not approved: Category 3 HIV/AIDS $22,317,891 $43,803,801
      Sudan, North CCM Not approved: Category 3 Malaria $30,681,228 $63,893,015
      Sudan, North CCM Not approved: Category 3 TB $7,729,768 $15,323,718
      Sudan, South Sub-CCM Not approved: Category 3 Malaria $15,032,552 $35,214,675
      Suriname CCM Not approved: Category 3 HIV/AIDS $3,562,265 $6,962,300
      Swaziland CCM Not approved: Category 3 HIV/AIDS $18,637,889 $67,462,405
      Swaziland CCM Not approved: Category 3 Malaria $543,228 $1,542,370
      Swaziland CCM Not approved: Category 3 TB $2,229,214 $7,978,066
      Syrian Arab Republic CCM Approved: Category 2 TB $4,578,047 $8,352,550
      Tajikistan CCM Approved: Category 2 HIV/AIDS $4,889,461 $12,096,246
      Tajikistan CCM Approved: Category 2B TB $7,500,683 $15,826,135
      Tanzania CCM Approved: Category 2 TB $17,815,916 $37,118,168
      Tanzania CCM Not approved: Category 3 HIV/AIDS $51,407,245 $166,125,608
      Tanzania CCM Not approved: Category 3 Malaria $77,708,340 $176,667,060
      Thailand CCM Approved: Category 2B TB $7,726,769 $19,627,001
      Thailand CCM Not approved: Category 3 HIV/AIDS $17,516,623 $44,824,259
      Thailand CCM Not approved: Category 3 Malaria $1,468,649 $3,600,024
      The Gambia CCM Approved: Category 2B Malaria $9,723,455 $20,813,258
      The Gambia CCM Not approved: Category 3 HIV/AIDS $4,237,260 $11,871,620
      Togo CCM Approved: Category 2 Malaria $5,837,547 $8,897,607
      Togo CCM Approved: Category 2B TB $2,818,756 $6,063,772
      Togo CCM Not approved: Category 3 HIV/AIDS $14,971,358 $36,481,655
      Tunisia CCM Approved: Category 2 HIV/AIDS $9,565,500 $17,383,000
      Turkmenistan CCM Not approved: Category 3 HIV/AIDS $3,390,668 $8,218,242
      Turkmenistan CCM Not approved: Category 3 TB $3,345,861 $8,651,009
      Turkmenistan CCM Not approved: Category 3 Malaria $553,550 $1,162,887
      Uganda CCM Approved: Category 2 TB $10,716,269 $26,030,098
      Uganda CCM Not approved: Category 3 HIV/AIDS $111,510,338 $190,774,209
      Uganda CCM Not approved: Category 3 Malaria $88,961,882 $151,105,762
      Ukraine CCM Approved: Category 2B HIV/AIDS $29,649,187 $151,077,434
      Uzbekistan CCM Not approved: Category 3 HIV/AIDS $5,198,212 $16,527,458
      Vietnam CCM Approved: Category 2 TB $1,614,335 $10,638,357
      Vietnam CCM Approved: Category 2B HIV/AIDS $10,219,180 $28,771,590
      Yemen CCM Not approved: Category 3 Malaria $5,869,195 $26,407,887
      Zambia CCM Not approved: Category 3 HIV/AIDS $30,818,587 $94,301,252
      Zambia CCM Not approved: Category 3 Malaria $3,374,100 $32,462,131
      Zambia CCM Not approved: Category 3 TB $7,275,794 $19,852,930
      Zanzibar CCM Approved: Category 2B HIV/AIDS $3,825,619 $8,792,041
      Zimbabwe CCM Not approved: Category 3 HIV/AIDS $33,249,082 $79,688,768

      Information on Round 6 grants will also be available shortly on the Global Fund website at www.theglobalfund.org/en/about/board/fourteenth.

      An applicant may appeal the board's decision if the applicant submitted an eligible proposal for a particular component in both Round 5 and Round 6 and was not approved in either case. The appeal must show that the recommendation made by the TRP regarding the Round 6 proposal was based on a "significant and obvious" error. The appeal must be filed with the Secretariat no later than 28 days from when the applicant receives written notice of the board's Round 6 decision. For further details regarding the appeals procedure, see www.theglobalfund.org/en/apply/proposals/appeals.
      "Reproduced from www.aidspan.org/gfo a service of Aidspan."




      Dr.Ashok Rau
      Executive Trustee/CEO
      Freedom Foundation-India,
      (Centers of Excellence- Substance Abuse & HIV/AIDS)
      Senior Research Fellow, The Terry Sanford Institute of Public Health, Duke University (USA)
      Visiting Faculty, Yale University (USA)
      Phone (O) +91 80 25440134, 25449766,
      Fax (O) +91 80 25440134




      _________________________________________________________________
      Call friends with PC-to-PC calling -- FREE
      http://get.live.com/messenger/overview
    • subhash chandorikar
      Dear Friends, The SEARCH organisation ( NGO )Pune,Maharashtra has arranged The Human Rights Campaighn for eunuchs.On Sunday 26th Nov.2006,at Dr.Babsaheb
      Message 2 of 2 , Nov 21, 2006
      • 0 Attachment
        Dear Friends,

        The SEARCH organisation ( NGO )Pune,Maharashtra has
        arranged The Human Rights Campaighn for eunuchs.On Sunday 26th Nov.2006,at
        Dr.Babsaheb Ambedkar Bhavan Pune at 5: 00 p.m.SEARCH organisation is
        honouring ten eunuchs who have servred humanity by doing charitable work
        for the eunuchs and civil society.We are honouring by the hand of the Famous
        film actor Dr.Shriram Lagoo,Joint Commissioner of Income tax
        Shri.D.D.Prabhakar,Prof.Vilas Wagh Chairman of Dr.Babasaheb Ambedkar study
        centre Pune Univercity and Corporator Smt.Snehal Padale will be chief
        guest.zzzzzOn the same programme We will publish reports of the seminars
        and training programmes.Eunuchs from Bombay,Ahemednager,Solapur and pune
        will join in the programme Each eunuch will share their work with the
        pariticipants.if anyone would like to join in this programme.Please join the
        programme,If you want give greetings
        which we can announce in the progrsmme or anyone want to provide information
        on the life of eunuchs please send on our email ID.

        Thanks.


        Acharya Subhash Chandorikar
        Director SEARCH Oraganisation
        A/1 Prince of Wales Drive Pune 411001
        EMail. searchsmc@... or subhashmc2000@...
        Mobile 9890836530




        >From: Ashok Rau <ashokrau@...>
        >Reply-To: arkitectindia@yahoogroups.com
        >To: <arkitectindia@yahoogroups.com>
        >Subject: [arkitectindia] RE: Global Fund - Round 6 Grants
        >Date: Sat, 4 Nov 2006 14:34:31 +0530
        >MIME-Version: 1.0
        >X-Originating-IP: 65.54.246.81
        >X-Originating-Email: [ashokrau@...]
        >X-Sender: ashokrau@...
        >Received: from n31.bullet.scd.yahoo.com ([66.94.237.25]) by
        >bay0-mc10-f3.bay0.hotmail.com with Microsoft SMTPSVC(6.0.3790.2444); Sat, 4
        >Nov 2006 02:36:07 -0800
        >Received: from [66.218.69.6] by n31.bullet.scd.yahoo.com with NNFMP; 04 Nov
        >2006 10:35:30 -0000
        >Received: from [66.218.67.98] by t6.bullet.scd.yahoo.com with NNFMP; 04 Nov
        >2006 10:35:30 -0000
        >Received: (qmail 72737 invoked from network); 4 Nov 2006 10:34:25 -0000
        >Received: from unknown (66.218.66.166) by m41.grp.scd.yahoo.com with QMQP;
        >4 Nov 2006 10:34:25 -0000
        >Received: from unknown (HELO n31.bullet.scd.yahoo.com) (66.94.237.25) by
        >mta5.grp.scd.yahoo.com with SMTP; 4 Nov 2006 10:34:25 -0000
        >Received: from [66.218.69.4] by n31.bullet.scd.yahoo.com with NNFMP; 04 Nov
        >2006 10:33:37 -0000
        >Received: from [66.218.66.70] by t4.bullet.scd.yahoo.com with NNFMP; 04 Nov
        >2006 10:33:37 -0000
        >Received: (qmail 31811 invoked from network); 4 Nov 2006 09:08:11 -0000
        >Received: from unknown (66.218.66.172) by m25.grp.scd.yahoo.com with QMQP;
        >4 Nov 2006 09:08:11 -0000
        >Received: from unknown (HELO bay0-omc1-s9.bay0.hotmail.com) (65.54.246.81)
        >by mta4.grp.scd.yahoo.com with SMTP; 4 Nov 2006 09:08:11 -0000
        >Received: from BAY118-W6 ([207.46.8.169]) by bay0-omc1-s9.bay0.hotmail.com
        >with Microsoft SMTPSVC(6.0.3790.1830); Sat, 4 Nov 2006 01:04:32 -0800
        >X-Message-Info: LsUYwwHHNt0VW58zsdbMUJWOAlv33C0khYp6qzbXD0k=
        >Comment: DomainKeys? See http://antispam.yahoo.com/domainkeys
        >DomainKey-Signature: a=rsa-sha1; q=dns; c=nofws; s=lima;
        >d=yahoogroups.com;b=JSnPKZaxGGaDPtkl1ppv4Pn4SU+j2sBjYMLCkImMZRpBiU8kCdrjExQBQxcZrdlPhPJ8zmhpeJv4Zc1+5ZXs0JYBYhO1dvuUpOwth82v+PXv+hgogsZmKkt/bNU9LISQ;
        >X-Yahoo-Newman-Id: 8951350-m3109
        >X-Apparently-To: arkitectindia@yahoogroups.com
        >X-OriginalArrivalTime: 04 Nov 2006 09:04:32.0108 (UTC)
        >FILETIME=[3DD28AC0:01C6FFF0]
        >X-eGroups-Msg-Info: 1:0:0:0
        >X-eGroups-Approved-By: arkitect95 <arkitect95@...> via web; 04 Nov
        >2006 10:33:36 -0000
        >Mailing-List: list arkitectindia@yahoogroups.com; contact
        >arkitectindia-owner@yahoogroups.com
        >Delivered-To: mailing list arkitectindia@yahoogroups.com
        >List-Id: <arkitectindia.yahoogroups.com>
        >Precedence: bulk
        >List-Unsubscribe: <mailto:arkitectindia-unsubscribe@yahoogroups.com>
        >X-Yahoo-Newman-Property:groups-email-trad
        >Return-Path:
        >sentto-8951350-3109-1162636530-searchsmc=hotmail.com@...
        >
        >
        >1. NEWS: Global Fund Approves Sixth Round of Grants
        >
        >The Global Fund board has approved 85 Round 6 grants that will cost $846
        >million over the first two years and $2,519 m. over five years. As a
        >result of recent new pledges, the Fund has sufficient money to pay for all
        >of these grants.
        >
        >2. NEWS: Round Six Decisions
        >
        >A detailed listing and analysis is provided of which Round 6 proposals have
        >been approved.
        >1. NEWS: Global Fund Approves Sixth Round of Grants
        >+ + + + + + + + + + + + + + + + + + +
        >
        >At its fourteenth board meeting held in Guatemala from Tuesday morning
        >through yesterday afternoon, Friday, the Global Fund board approved 85
        >Round 6 grants that will cost $846 million over the first two years and
        >$2,519 m. over five years. (For a complete list of approved and
        >non-approved proposals, see below.) As a result of recent new pledges, the
        >Fund has sufficient money to pay for all grants that were recommended by
        >the Technical Review Panel.
        >
        >In Round 6, the two-year cost of all eligible submitted proposals was down
        >24% from the Round 5 level; but the cost of those actually approved was up
        >17% from the Round 5 level. This was mainly because the percentage of
        >proposals approved went up from 31% in Round 5 to 43% in Round 6. The
        >average cost of the first two years of each Round 6 approved proposal was
        >$10 million, down from $11.5 million in Round 5.
        >
        >In Round 6, an unusually high 62% of TB proposals were approved, up from
        >46% in Round 5. The percentages of HIV/AIDS and malaria proposals approved
        >were 39% and 32%, respectively.
        >
        >The success rates by region ranged from 24% (4 proposals approved out of 17
        >submitted) in Latin America and the Caribbean, to 77% (10 out of 13) in the
        >Western Pacific. The Western Pacific has had the highest success rates in
        >all of the last three Rounds.
        >
        >The Board's decisions as to which proposals to approve was, as always,
        >entirely based on the advice it received from the Technical Review Panel
        >(TRP), an independent body of 26 experts from around the world. No board
        >members or Secretariat employees are members of the TRP.
        >
        >The following tables summarize Round 6 results.
        >
        >Table 1: Results by Round
        >
        > Number of eligible proposals Percent Budget for Years 1-2 Percent
        >Round 1: Submitted 204 100% c. $1,500 m. 100%
        > Of which, Approved 58 28% $578 m. c. 39%
        >
        >Round 2: Submitted 229 100% $2,137 m. 100%
        > Of which, Approved 98 43% $878 m. 41%
        >
        >Round 3: Submitted 180 100% $1,853 m. 100%
        > Of which, Approved 71 39% $623 m. 34%
        >
        >Round 4: Submitted 173 100% $2,512 m. 100%
        > Of which, Approved 69 40% $968 m. 39%
        >
        >Round 5: Submitted 202 100% $3,298 m. 100%
        > Of which, Approved 63 31% $726 m. 22%
        >
        >Round 6: Submitted 196 100% $2,519 m. 100%
        > Of which, Approved 85 43% $846 m. 34%
        >
        >
        >Table 2: Disease Component Results by Round
        >
        > No. of eligible proposals submitted,
        >number approved, and
        >% of submitted proposals approved Budget for Years 1-2 of approved
        >proposals
        > Round 4 Round 5 Round 6 Round 4 Round 5 Round 6
        >HIV/AIDS 72 27 38% 67 25 37% 82 32 39% $468 m. (48%) $288 m. (40%) $453
        >m. (54%)
        >Malaria 46 23 50% 57 13 23% 59 19 32% $406 m. (42%) $198 m. (27%) $203
        >m. (24%)
        >TB 48 19 40% 48 22 46% 55 34 62% $94 m. (10%) $197 m. (27%) $190 m. (22%)
        >Other 7 0 0% 30 3 10% n/a $0 m. (0%) $43 m. (6%) n/a
        >TOTAL 173 69 40% 202 63 31% 196 85 43% $968 m. (100%) $726 m. (100%) $846
        >m. (100%)
        >
        >
        >Table 3: Region Results by Round
        >
        > No. of eligible proposals submitted,
        >number approved, and
        >% of submitted proposals approved Budget for Years 1-2 of approved
        >proposals
        > Round 4 Round 5 Round 6 Round 4 Round 5 Round 6
        >Africa 86 34 40% 105 32 30% 93 32 34% $663 m. (68%) $484 m. (67%) $381
        >m. (45%)
        >Southeast Asia 18 8 44% 19 3 16% 21 11 52% $111 m. (11%) $33 m. (5%) $165
        >m. (19%)
        >Western Pacific 17 9 53% 17 10 59% 13 10 77% $84 m. (9%) $91 m. (13%) $72
        >m. (9%)
        >Eastern Med. 17 5 29% 27 4 15% 25 11 44% $31 m. (3%) $28 m. (4%) $62
        >m. (7%)
        >Europe 21 7 33% 21 9 43% 27 17 63% $53 m. (5%) $26 m. (4%) $119 m. (14%)
        >Americas 14 6 43% 13 5 38% 17 4 24% $26 m. (3%) $64 m. (9%) $48 m. (6%)
        >TOTAL 173 69 40% 202 63 31% 196 85 43% $968 m. (100%) $726 m. (100%) $846
        >m. (100%)
        >
        >
        >Table 4: Outcome of Secretariat Screening Panel Review of Eligibility, by
        >Round
        >
        > Round 5 Round 6
        >Type of Applicant Number of Applicants Eligible Applicants Number of
        >Applicants Eligible Applicants
        >CCM 90 89 96 93
        >Sub-CCM 1 1 1 1
        >Regional Organization 9 2 10 9
        >Regional Coordinating Mechanism 3 3 1 1
        >Non-CCM 64 3 36 4
        >Total 167 98 (59%) 144 108 (75%)
        >
        >Other highlights of Round 6 include the following:
        >
        >� The TRP commented, �In some cases, for reasons the TRP cannot
        >comprehend, some applicants appear to repeatedly ignore the TRP�s advice
        >and comments on prior proposals. These are in stark contrast to the many
        >applicants in Round 6 who provided specific and adequate responses to all
        >or most of the weaknesses identified in their prior proposals. Where this
        >was the case, these proposals usually tended to be recommended for funding
        >in Round 6. The TRP believes that directly and comprehensively addressing
        >the problems identified in a prior unsuccessful proposal is perhaps the
        >most effective approach to ensuring a successful new application.�
        >
        >� In Round 6, three approved proposals had five-year budgets in excess of
        >$100 million. These were from India (HIV/AIDS, $259 m.), Ukraine
        >(HIV/AIDS, $151 m.) and South Africa (HIV/AIDS, $103 m.). And eight
        >non-approved proposals had five-year budgets in excess of $100 million.
        >These were from Democratic Republic of Congo, Ethiopia, Haiti, Madagascar,
        >Tanzania (2 proposals) and Uganda (2 proposals).
        >
        >� As always, and as required by the Board, the TRP did not take into
        >account availability of funds when it decided which proposals to recommend
        >for approval.
        >
        >� The budget breakdown of the approved Round 6 proposals was: drugs 15%
        >(down from 21% in Round 5); commodities 22%; planning and administration
        >18%; human resources 13%; infrastructure 11%; training 12%; and other 9%.
        >
        >� The Round 6 success rate is equal to the highest ever success rate of
        >43%, which was recorded in Round 2.
        >
        >� The TRP commented, �The trend, noted in Round 5, away from very large and
        >ambitious scale up programs of antiretroviral therapy was again a feature
        >of Round 6. In this Round, the vast majority of HIV/AIDS proposals were of
        >a more modest nature, perhaps reflecting the understanding by applicant
        >countries of the difficulties of implementing very large scale programs
        >over a relatively short period of time.�
        >
        >� Further details are available below.
        >Based on advise from the Technical Review Panel (TRP), the Board divides
        >eligible proposals into five Categories, as follows:
        >
        >� Category 1: Approved proposals requiring no or minor
        >clarifications, which need to be provided within 4 weeks and then given a
        >final approval by the TRP Chair and/or Vice-Chair.
        >
        >� Category 2: Proposals that are provisionally approved subject to
        >the required clarifications being provided within a limited timeframe (6
        >weeks for the applicant to respond to the TRP queries, 4 months to obtain
        >the final TRP approval should further clarifications be requested). The
        >primary reviewer and secondary reviewer as well as TRP Chair and /or
        >Vice-Chair need to give final approval.
        >
        >� Category 2B: Similar to Category 2A, but regarded as relatively
        >weak, on grounds of technical merit and/or issues of feasibility and
        >likelihood of effective implementation.
        >
        >� Category 3: Not approved in their present form, but applicants
        >are encouraged to submit an improved proposal in some future Round.
        >
        >� Category 4: Rejected.
        >
        >The number of Round 6 grants per Category was as follows:
        >
        >Table 5: Round 6 results by Category
        >
        >Explanation Number of proposals Budget
        >Years 1-2 Budget
        >Years 1-5
        >Approved: Category 1 9 $69 m. $150 m.
        >Approved: Category 2 48 $437 m. $977 m.
        >Approved: Category 2B 28 $341 m. $929 m.
        >Subtotal: All Approved Proposals: 85 $846 m. $2,056 m.
        >Not Approved: Category 3 97 $1,519 m. $3,747 m.
        >Not Approved: Category 4 14 $154 m. $305 m.
        >Subtotal: All Non-Approved Proposals: 111 $1,673 m. $4,052 m.
        >Total: All Proposals 196 $2,519 m. $6,108 m.
        >
        >
        >Round 6 results by country were as follows:
        >
        >Table 6: Round 6 results by country
        >
        >Country / Countries Applicant Decision Component Budget
        >Years 1-2 Budget
        >Years 1-5
        >Afghanistan CCM Not approved: Category 3 HIV/AIDS $15,481,701 $35,820,001
        >Afghanistan CCM Not approved: Category 3 TB $15,458,931 $37,964,223
        >Armenia CCM Not approved: Category 4 Malaria $1,716,380 $2,804,333
        >Azerbaijan CCM Not approved: Category 3 Malaria $2,438,744 $4,834,597
        >Bangladesh CCM Approved: Category 1 Malaria $18,587,179 $39,062,586
        >Bangladesh CCM Approved: Category 2B HIV/AIDS $13,998,844 $40,002,452
        >Belarus CCM Approved: Category 2B TB $6,083,814 $14,774,359
        >Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua,
        >Panama Regional Org. (Central American network for persons living with
        >HIV/AIDS) Not approved: Category 4 HIV/AIDS $6,118,200 $13,518,001
        >Benin CCM Approved: Category 2 TB $4,812,685 $9,401,518
        >Benin CCM Not approved: Category 3 Malaria $14,164,549 $40,140,099
        >Benin, Burkina Faso, Central African Republic, C�te d�Ivoire, Liberia,
        >Mali Regional Org. (UN Foundation, for the Measles-Malaria Partnership) Not
        >approved: Category 4 Malaria $45,797,837 $45,797,837
        >Bhutan CCM Approved: Category 2 TB $884,690 $1,773,135
        >Bhutan CCM Approved: Category 2B HIV/AIDS $1,812,825 $3,596,325
        >Bhutan CCM Not approved: Category 3 Malaria $1,834,725 $3,819,875
        >Bosnia and Herzegovina CCM Approved: Category 2B TB $3,302,606 $6,880,708
        >Botswana CCM Not approved: Category 3 TB $2,066,795 $2,898,720
        >Botswana, Lesotho, Malawi, Mozambique, Namibia, South Africa, Swaziland,
        >Tanzania, Zambia, Zimbabwe Regional Org. (Soul City: Institute for Health
        >and Development Communication) Not approved: Category
        >4 HIV/AIDS $27,511,611 $76,135,198
        >Bulgaria CCM Approved: Category 2B TB $8,968,233 $19,703,709
        >Burkina Faso CCM Approved: Category 2 HIV/AIDS $27,691,230 $60,000,048
        >Burkina Faso CCM Not approved: Category 3 Malaria $12,169,089 $27,852,482
        >Burundi CCM Not approved: Category 3 Malaria $13,881,173 $25,421,843
        >Burundi, DRC, Kenya, Rwanda, Uganda, Tanzania Regional Org. (Great Lakes
        >Initiative On HIV/AIDS) Not approved: Category 4 HIV/AIDS $16,380,500
        > $35,398,100
        >Burundi, Rwanda Regional Org. (East African Network for Monitoring
        >Antimalarial Treatment) Not approved: Category 4 Malaria $3,006,181
        > $3,923,349
        >Cambodia CCM Approved: Category 2 Malaria $13,148,613 $31,191,393
        >Cambodia CCM Not approved: Category 3 HIV/AIDS $13,796,409 $54,225,879
        >Cambodia CCM Not approved: Category 3 TB $2,192,363 $6,125,536
        >Cameroon CCM Not approved: Category 3 HIV/AIDS $8,842,899 $15,579,150
        >Cameroon CCM Not approved: Category 3 Malaria $9,522,466 $27,387,624
        >Cameroon CCM Not approved: Category 3 TB $11,554,563 $18,557,034
        >Central African Republic CCM Not approved: Category 3 HIV/AIDS $9,940,350
        > $33,723,417
        >Central African Republic CCM Not approved: Category 3 Malaria $5,875,492
        > $8,011,650
        >Central African Republic, Congo, Equatorial Guinea, Gabon Regional Org.
        >(Secretary General of Economic Community of Central African States) Not
        >approved: Category 3 HIV/AIDS $6,657,961 $16,391,154
        >Chad CCM Not approved: Category 3 Malaria $9,696,237 $32,008,824
        >China CCM Approved: Category 2 HIV/AIDS $5,812,875 $14,395,715
        >China CCM Approved: Category 2B Malaria $7,047,932 $16,808,186
        >Colombia CCM Not approved: Category 3 HIV/AIDS $12,506,437 $28,517,825
        >Comoros CCM Not approved: Category 3 HIV/AIDS $3,423,946 $7,213,882
        >Comoros CCM Not approved: Category 3 Malaria $4,022,831 $7,993,136
        >Congo CCM Not approved: Category 3 Malaria $28,013,479 $48,624,009
        >Congo (DR of) CCM Approved: Category 2 TB $8,532,576 $12,098,109
        >Congo (DR of) CCM Not approved: Category 3 HIV/AIDS $42,120,821
        > $130,540,223
        >Congo (DR of) CCM Not approved: Category 3 Malaria $25,868,570 $37,846,540
        >C�te d�Ivoire CCM Approved: Category 2 Malaria $9,121,504 $17,271,965
        >C�te d�Ivoire CCM Approved: Category 2B TB $3,489,404 $7,068,427
        >C�te d�Ivoire CCM Not approved: Category 3 HIV/AIDS $12,130,403 $50,061,748
        >C�te d�Ivoire, Ghana, Togo, Benin, Nigeria Regional Org. (Abidjan-Lagos
        >Corridor Organization) Approved: Category 2 HIV/AIDS $19,122,500
        > $45,610,500
        >C�te d�Ivoire, Guinea, Liberia, Sierra Leone Regional Org. (Mano River
        >Union Secretariat) Not approved: Category 3 HIV/AIDS $15,472,689
        > $27,527,333
        >Cuba CCM Approved: Category 2 HIV/AIDS $14,369,743 $36,123,056
        >Cuba CCM Not approved: Category 3 TB $3,497,417 $9,686,494
        >Dijbouti CCM Approved: Category 2 HIV/AIDS $2,719,910 $11,298,977
        >Dijbouti CCM Approved: Category 2 Malaria $2,611,945 $3,933,976
        >Dijbouti CCM Approved: Category 2 TB $1,143,735 $3,558,810
        >Dominican Republic CCM Not approved: Category 3 Malaria $2,994,675
        > $6,267,052
        >Ecuador, Guatemala, Mexico, Nicaragua, Peru, Uraguay Regional Coordinating
        >Mechanism Not approved: Category 4 HIV/AIDS $12,189,750 $28,955,156
        >Egypt CCM Approved: Category 2B TB $5,375,548 $9,965,390
        >Egypt CCM Not approved: Category 3 HIV/AIDS $5,412,750 $11,619,700
        >El Salvador CCM Not approved: Category 3 HIV/AIDS $15,342,600 $37,821,680
        >El Salvador CCM Not approved: Category 3 TB $3,283,596 $8,497,574
        >Eritrea CCM Approved: Category 2 Malaria $5,943,130 $13,374,247
        >Eritrea CCM Approved: Category 2 TB $5,578,834 $13,302,028
        >Ethiopia CCM Approved: Category 2B TB $12,104,974 $44,434,133
        >Ethiopia CCM Not approved: Category 3 HIV/AIDS $56,494,994 $193,864,789
        >Ethiopia CCM Not approved: Category 3 Malaria $17,162,130 $49,947,701
        >Gabon CCM Not approved: Category 4 Malaria $8,338,037 $20,546,237
        >Georgia CCM Approved: Category 1 TB $9,345,636 $10,955,450
        >Georgia CCM Approved: Category 2 HIV/AIDS $6,194,362 $11,449,497
        >Georgia CCM Approved: Category 2 Malaria $1,664,960 $3,334,190
        >Guatemala CCM Approved: Category 2 TB $3,733,873 $8,136,149
        >Guinea CCM Approved: Category 2 HIV/AIDS $4,859,358 $20,419,474
        >Guinea CCM Approved: Category 2B Malaria $17,349,399 $26,978,927
        >Guinea-Bissau CCM Approved: Category 2B Malaria $3,438,484 $12,816,656
        >Guinea-Bissau CCM Not approved: Category 3 HIV/AIDS $6,715,035 $20,933,476
        >Guinea-Bissau CCM Not approved: Category 3 TB $1,503,686 $3,381,515
        >Haiti CCM Not approved: Category 3 HIV/AIDS $48,422,668 $137,232,190
        >Honduras CCM Not approved: Category 3 HIV/AIDS $17,810,301 $38,376,897
        >Honduras CCM Not approved: Category 3 Malaria $6,493,366 $12,825,085
        >Honduras CCM Not approved: Category 3 TB $6,315,790 $11,052,632
        >India CCM Approved: Category 2 TB $9,072,464 $24,271,555
        >India CCM Approved: Category 2B HIV/AIDS $75,954,670 $259,211,574
        >India CCM Not approved: Category 3 Malaria $14,763,903 $39,267,508
        >Indonesia CCM Approved: Category 2 Malaria $27,727,920 $57,965,100
        >Indonesia CCM Not approved: Category 3 HIV/AIDS $5,190,619 $14,735,703
        >Iraq CCM Approved: Category 1 TB $6,443,900 $14,553,900
        >Iraq CCM Not approved: Category 3 HIV/AIDS $4,272,326 $4,272,326
        >Iraq CCM Not approved: Category 3 Malaria $3,179,244 $6,543,244
        >Jordan CCM Approved: Category 2 HIV/AIDS $3,069,508 $6,800,716
        >Kazakhstan CCM Approved: Category 1 TB $5,442,598 $9,842,621
        >Kenya CCM Not approved: Category 3 HIV/AIDS $13,686,258 $26,767,049
        >Kenya CCM Not approved: Category 4 Malaria $4,082,093 $8,873,241
        >Kenya, Uganda Regional Org. (Global Health Action, Inc.) Not approved:
        >Category 4 HIV/AIDS $7,426,148 $19,693,769
        >Kenyan CCM Approved: Category 2 TB $4,217,269 $9,171,790
        >Kosovo CCM Not approved: Category 3 HIV/AIDS $2,772,782 $5,926,482
        >Kosovo Non-CCM (ALB-MED) Not approved: Category 4 HIV/AIDS $738,109
        > $738,109
        >Kyrgyzstan CCM Approved: Category 2 TB $4,244,578 $9,995,446
        >Lao PDR CCM Approved: Category 2 HIV/AIDS $3,418,698 $8,978,927
        >Lao PDR CCM Approved: Category 2 Malaria $1,726,701 $4,099,092
        >Lesotho CCM Approved: Category 2B TB $3,829,664 $6,581,970
        >Lesotho CCM Not approved: Category 3 HIV/AIDS $15,145,130 $52,727,643
        >Liberia CCM Approved: Category 2B HIV/AIDS $13,857,723 $44,281,569
        >Liberia CCM Not approved: Category 3 Malaria $15,558,819 $29,368,547
        >Liberia CCM Not approved: Category 3 TB $5,746,059 $13,409,498
        >Macedonia CCM Not approved: Category 3 HIV/AIDS $5,987,500 $14,957,266
        >Madagascar CCM Not approved: Category 3 HIV/AIDS $23,925,565 $51,570,146
        >Madagascar CCM Not approved: Category 3 Malaria $72,297,995 $225,433,100
        >Madagascar CCM Not approved: Category 3 TB $4,082,076 $8,736,174
        >Malawi CCM Not approved: Category 3 HIV/AIDS $35,229,821 $90,403,880
        >Malawi CCM Not approved: Category 3 Malaria $17,996,090 $64,952,812
        >Maldives CCM Approved: Category 2B HIV/AIDS $2,655,685 $4,865,956
        >Mali CCM Approved: Category 2B Malaria $9,222,572 $26,659,632
        >Mauritania CCM Approved: Category 2 Malaria $4,495,126 $14,502,141
        >Mauritania CCM Approved: Category 2 TB $4,441,686 $9,352,445
        >Moldova CCM Approved: Category 1 HIV/AIDS $6,411,072 $15,940,711
        >Moldova CCM Approved: Category 2 TB $5,786,890 $11,976,633
        >Mongolia CCM Not approved: Category 3 HIV/AIDS $5,214,505 $12,138,067
        >Montenegro CCM Approved: Category 1 TB $1,073,811 $1,651,006
        >Morocco CCM Approved: Category 2 HIV/AIDS $10,680,798 $26,453,910
        >Morocco CCM Approved: Category 2 TB $2,221,975 $4,157,800
        >Mozambique CCM Approved: Category 2 HIV/AIDS $22,748,853 $76,044,549
        >Mozambique CCM Approved: Category 2B Malaria $25,591,825 $36,747,308
        >Mozambique CCM Not approved: Category 3 TB $16,721,868 $25,026,133
        >Namibia CCM Approved: Category 2 Malaria $9,919,565 $15,820,160
        >Namibia CCM Not approved: Category 3 HIV/AIDS $13,312,950 $50,303,667
        >Nepal CCM Not approved: Category 3 HIV/AIDS $8,739,192 $29,034,173
        >Nepal CCM Not approved: Category 3 Malaria $5,187,646 $17,863,993
        >Nepal CCM Not approved: Category 3 TB $4,589,953 $15,961,562
        >Nepal Non-CCM (Family Health International) Not approved: Category
        >4 HIV/AIDS $7,381,007 $21,105,841
        >Niger CCM Not approved: Category 3 HIV/AIDS $7,537,006 $21,959,530
        >Niger CCM Not approved: Category 3 TB $5,648,199 $8,184,993
        >Niger CCM Not approved: Category 4 Malaria $12,254,867 $25,632,832
        >Nigeria CCM Not approved: Category 3 HIV/AIDS $3,836,085 $22,599,482
        >Nigeria CCM Not approved: Category 3 Malaria $29,152,570 $30,709,320
        >Pakistan CCM Not approved: Category 3 HIV/AIDS $21,827,272 $73,733,095
        >Pakistan CCM Not approved: Category 3 Malaria $7,270,655 $15,901,134
        >Pakistan CCM Not approved: Category 3 TB $22,568,553 $56,020,759
        >Papua New Guinea CCM Approved: Category 1 TB $5,007,912 $20,869,303
        >Paraguay CCM Approved: Category 1 HIV/AIDS $3,471,892 $9,110,757
        >Peru CCM Approved: Category 2B HIV/AIDS $26,396,819 $41,348,625
        >Peru CCM Not approved: Category 3 TB $27,679,354 $55,822,507
        >Philippines CCM Approved: Category 2B HIV/AIDS $7,474,964 $18,434,190
        >Philippines CCM Approved: Category 2B Malaria $16,297,659 $22,344,786
        >Romania CCM Approved: Category 2 HIV/AIDS $8,229,885 $11,567,365
        >Romania CCM Approved: Category 2 TB $4,606,269 $10,200,345
        >Rwanda CCM Approved: Category 2 HIV/AIDS $31,563,456 $58,917,110
        >Rwanda CCM Approved: Category 2 TB $2,779,743 $7,525,352
        >Rwanda CCM Not approved: Category 3 Malaria $7,296,260 $10,716,123
        >S�n�gal CCM Approved: Category 2 HIV/AIDS $10,368,195 $28,893,265
        >S�n�gal CCM Not approved: Category 3 TB $7,839,600 $14,925,041
        >Serbia CCM Approved: Category 2 HIV/AIDS $5,922,119 $12,159,491
        >Sierra Leone CCM Approved: Category 2 HIV/AIDS $9,627,939 $26,482,276
        >Sierra Leone CCM Not approved: Category 3 Malaria $20,536,213 $28,436,907
        >Sierra Leone CCM Not approved: Category 3 TB $6,602,108 $15,264,339
        >Somalia Non-CCM (Somalia Aid Coordination Body Health Sector
        >Committee) Approved: Category 1 Malaria $13,096,942 $27,679,264
        >Somalia Non-CCM (AMIRDF) Not approved: Category 4 HIV/AIDS $575,000
        > $1,400,000
        >South Africa CCM Approved: Category 2 HIV/AIDS $55,771,311 $102,813,863
        >Sri Lanka CCM Approved: Category 2 HIV/AIDS $1,009,760 $1,884,360
        >Sri Lanka CCM Approved: Category 2B TB $5,190,641 $14,291,187
        >Sri Lanka CCM Not approved: Category 3 Malaria $5,477,185 $12,294,174
        >Sudan, North CCM Not approved: Category 3 HIV/AIDS $22,317,891 $43,803,801
        >Sudan, North CCM Not approved: Category 3 Malaria $30,681,228 $63,893,015
        >Sudan, North CCM Not approved: Category 3 TB $7,729,768 $15,323,718
        >Sudan, South Sub-CCM Not approved: Category 3 Malaria $15,032,552
        > $35,214,675
        >Suriname CCM Not approved: Category 3 HIV/AIDS $3,562,265 $6,962,300
        >Swaziland CCM Not approved: Category 3 HIV/AIDS $18,637,889 $67,462,405
        >Swaziland CCM Not approved: Category 3 Malaria $543,228 $1,542,370
        >Swaziland CCM Not approved: Category 3 TB $2,229,214 $7,978,066
        >Syrian Arab Republic CCM Approved: Category 2 TB $4,578,047 $8,352,550
        >Tajikistan CCM Approved: Category 2 HIV/AIDS $4,889,461 $12,096,246
        >Tajikistan CCM Approved: Category 2B TB $7,500,683 $15,826,135
        >Tanzania CCM Approved: Category 2 TB $17,815,916 $37,118,168
        >Tanzania CCM Not approved: Category 3 HIV/AIDS $51,407,245 $166,125,608
        >Tanzania CCM Not approved: Category 3 Malaria $77,708,340 $176,667,060
        >Thailand CCM Approved: Category 2B TB $7,726,769 $19,627,001
        >Thailand CCM Not approved: Category 3 HIV/AIDS $17,516,623 $44,824,259
        >Thailand CCM Not approved: Category 3 Malaria $1,468,649 $3,600,024
        >The Gambia CCM Approved: Category 2B Malaria $9,723,455 $20,813,258
        >The Gambia CCM Not approved: Category 3 HIV/AIDS $4,237,260 $11,871,620
        >Togo CCM Approved: Category 2 Malaria $5,837,547 $8,897,607
        >Togo CCM Approved: Category 2B TB $2,818,756 $6,063,772
        >Togo CCM Not approved: Category 3 HIV/AIDS $14,971,358 $36,481,655
        >Tunisia CCM Approved: Category 2 HIV/AIDS $9,565,500 $17,383,000
        >Turkmenistan CCM Not approved: Category 3 HIV/AIDS $3,390,668 $8,218,242
        >Turkmenistan CCM Not approved: Category 3 TB $3,345,861 $8,651,009
        >Turkmenistan CCM Not approved: Category 3 Malaria $553,550 $1,162,887
        >Uganda CCM Approved: Category 2 TB $10,716,269 $26,030,098
        >Uganda CCM Not approved: Category 3 HIV/AIDS $111,510,338 $190,774,209
        >Uganda CCM Not approved: Category 3 Malaria $88,961,882 $151,105,762
        >Ukraine CCM Approved: Category 2B HIV/AIDS $29,649,187 $151,077,434
        >Uzbekistan CCM Not approved: Category 3 HIV/AIDS $5,198,212 $16,527,458
        >Vietnam CCM Approved: Category 2 TB $1,614,335 $10,638,357
        >Vietnam CCM Approved: Category 2B HIV/AIDS $10,219,180 $28,771,590
        >Yemen CCM Not approved: Category 3 Malaria $5,869,195 $26,407,887
        >Zambia CCM Not approved: Category 3 HIV/AIDS $30,818,587 $94,301,252
        >Zambia CCM Not approved: Category 3 Malaria $3,374,100 $32,462,131
        >Zambia CCM Not approved: Category 3 TB $7,275,794 $19,852,930
        >Zanzibar CCM Approved: Category 2B HIV/AIDS $3,825,619 $8,792,041
        >Zimbabwe CCM Not approved: Category 3 HIV/AIDS $33,249,082 $79,688,768
        >
        >Information on Round 6 grants will also be available shortly on the Global
        >Fund website at www.theglobalfund.org/en/about/board/fourteenth.
        >
        >An applicant may appeal the board's decision if the applicant submitted an
        >eligible proposal for a particular component in both Round 5 and Round 6
        >and was not approved in either case. The appeal must show that the
        >recommendation made by the TRP regarding the Round 6 proposal was based on
        >a "significant and obvious" error. The appeal must be filed with the
        >Secretariat no later than 28 days from when the applicant receives written
        >notice of the board's Round 6 decision. For further details regarding the
        >appeals procedure, see www.theglobalfund.org/en/apply/proposals/appeals.
        > "Reproduced from www.aidspan.org/gfo a service of Aidspan."
        >
        >
        >
        >
        > Dr.Ashok Rau
        > Executive Trustee/CEO
        > Freedom Foundation-India,
        >(Centers of Excellence- Substance Abuse & HIV/AIDS)
        >Senior Research Fellow, The Terry Sanford Institute of Public Health, Duke
        >University (USA)
        >Visiting Faculty, Yale University (USA)
        >Phone (O) +91 80 25440134, 25449766,
        >Fax (O) +91 80 25440134
        >
        >
        >
        >
        >_________________________________________________________________
        >Call friends with PC-to-PC calling -- FREE
        >http://get.live.com/messenger/overview
        >
        >
        >
        >
        >Yahoo! Groups Links
        >
        >
        >
        >

        _________________________________________________________________
        Spice up your IM conversations. New, colorful and animated emoticons. Get
        chatting! http://server1.msn.co.in/SP05/emoticons/
      Your message has been successfully submitted and would be delivered to recipients shortly.